
Consider Hyperliquid (HYPE) for its exceptional strength driven by a token buyback mechanism, or its publicly traded proxy PER for US investors seeking exposure. With Bitcoin facing short-term headwinds, gold and silver are presented as a stronger investment after a healthy correction has reset their bullish trend. The AI-focused pharmaceutical sector is outperforming the broader market, with companies like Eli Lilly (LLY), Novartis (NVS), and Merck & Co. (MRK) showing resilience. These companies are leveraging AI to accelerate drug development, providing a strong tailwind for growth. Exercise caution with Bitcoin (BTC), as it may see further downside toward a support level of $64,000 before a potential long-term bottom in Q2 2026.

By @realvisionfinance
We arm you with the knowledge, the tools, and the network to succeed on your financial journey.